David P Reichwein

David P. Reichwein serves as Chief Executive Officer of Vertex Pharmaceuticals Incorporated, a Boston-based biotechnology company focused on rare diseases. He joined Vertex in 2020 as Chief Operating Officer before being promoted to CEO in 2022, succeeding Reshma Kewalramani. Reichwein previously held executive positions at Alexion Pharmaceuticals and has extensive experience in biopharmaceutical operations and commercial strategy.